Arcus Biosciences, Inc. Detailed Financials
Full historical quarterly statements
| Metric | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 17.0M | 33.0M | 26.0M | 160.0M | 28.0M | 26.0M | 48.0M | 39.0M |
| Cost of Goods Sold | 2.0M | 3.0M | 2.0M | 0 | 0 | 0 | 0 | 0 |
| Gross Profit | 15.0M | 30.0M | 24.0M | 160.0M | 28.0M | 26.0M | 48.0M | 39.0M |
| R&D Expenses | 122.0M | 121.0M | 141.0M | 139.0M | 122.0M | 101.0M | 123.0M | 115.0M |
| Operating Expenses | 149.0M | 144.0M | 166.0M | 168.0M | 150.0M | 129.0M | 153.0M | 145.0M |
| Operating Income | -134.0M | -114.0M | -142.0M | -8.0M | -122.0M | -103.0M | -105.0M | -106.0M |
| Other Income / Gains | 6.0M | 16.0M | 7.0M | 0 | 10.0M | 9.0M | 13.0M | 13.0M |
| Net Income | -128.0M | -98.0M | -135.0M | -8.0M | -112.0M | -94.0M | -92.0M | -93.0M |
| EPS (Diluted) | -1.02 | -0.92 | -1.27 | 0.043 | -1.14 | -1.03 | -1.01 | -1.02 |
| Reported Currency | USD | USD | USD | USD | USD | USD | USD | USD |
| Gross Profit Ratio | 0.882 | 0.909 | 0.923 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| General And Administrative Expenses | 29.0M | 26.0M | 27.0M | 29.0M | 28.0M | 28.0M | 30.0M | 30.0M |
| Selling And Marketing Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Selling General And Administrative Expenses | 29.0M | 26.0M | 27.0M | 29.0M | 28.0M | 28.0M | 30.0M | 30.0M |
| Other Expenses | -2.0M | -3.0M | -2.0M | 0 | 0 | 0 | 0 | 0 |
| Cost And Expenses | 151.0M | 147.0M | 168.0M | 168.0M | 150.0M | 129.0M | 153.0M | 145.0M |
| Interest Income | 0 | 31.0M | 10.0M | 10.0M | 11.0M | 12.0M | 14.0M | 13.0M |
| Interest Expense | 3.0M | 14.0M | 3.0M | 2.0M | 1.0M | 2.0M | 1.0M | 0 |
| Depreciation And Amortization | 2.0M | 3.0M | 2.0M | 2.0M | 3.0M | 3.0M | 2.0M | 2.0M |
| Ebitda | -123.0M | -81.0M | -130.0M | 4.0M | -108.0M | -89.0M | -89.0M | -91.0M |
| Ebitdaratio | -7.235 | -2.455 | -5.00 | 0.025 | -3.857 | -3.423 | -1.854 | -2.333 |
| Operating Income Ratio | -7.882 | -3.455 | -5.462 | -0.05 | -4.357 | -3.962 | -2.188 | -2.718 |
| Income Before Tax | -128.0M | -98.0M | -135.0M | -8.0M | -112.0M | -94.0M | -92.0M | -93.0M |
| Income Before Tax Ratio | -7.529 | -2.97 | -5.192 | -0.05 | -4.00 | -3.615 | -1.917 | -2.385 |
| Income Tax Expense | 0 | 0 | 0 | 0 | 0 | 1.0M | 0 | 0 |
| Net Income Ratio | -7.529 | -2.97 | -5.192 | -0.05 | -4.00 | -3.615 | -1.917 | -2.385 |
| Epsdiluted | -1.02 | -0.92 | -1.27 | 0.043 | -1.14 | -1.03 | -1.01 | -1.02 |
| Weighted Average Shs Out | 125.4M | 107.4M | 106.5M | 106.1M | 98.4M | 91.7M | 91.4M | 91.1M |
| Weighted Average Shs Out Dil | 125.4M | 107.4M | 106.5M | 106.5M | 98.4M | 91.7M | 91.4M | 91.1M |